Amneal Pharmaceuticals (AMRX) EV to FCF (2018 - 2026)

Amneal Pharmaceuticals has reported EV to FCF for 9 years, with the latest figure at 105.59 in Q2 2026.

• On a quarterly basis, EV to FCF fell 354.02% year-over-year to 105.59 in Q2 2026; TTM through Jun 2026 was 42.9, a 378.89% increase from a year earlier, with the FY2025 full-year figure at 13.93, up 40.58% from the prior year.
• EV to FCF was 105.59 for Q2 2026 at Amneal Pharmaceuticals, up from 110.36 in the prior quarter.
• The five-year high for EV to FCF was 68.04 in Q2 2024, with the low at 458.79 in Q1 2025.
• Average EV to FCF over 5 years is 33.64, with a median of 8.56 recorded in 2022.
• The largest YoY upside for EV to FCF was 282.19% in 2024 against a maximum downside of 5914.79% in 2024.
• Over 5 years, EV to FCF stood at 17.35 in 2022, then soared by 182.81% to 14.37 in 2023, then surged by 62.91% to 23.41 in 2024, then soared by 47.96% to 34.64 in 2025, then slumped by 404.84% to 105.59 in 2026.
• The last three EV to FCF figures came in at 105.59 (Q2 2026), 110.36 (Q1 2026), and 34.64 (Q4 2025), per Business Quant data.